| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.53 | 0.05 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |